{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:11:16Z","timestamp":1794715876332,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T00:00:00Z","timestamp":1409961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00277-014-2188-8","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T05:26:49Z","timestamp":1409894809000},"page":"239-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients"],"prefix":"10.1007","volume":"94","author":[{"given":"Pengpeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,6]]},"reference":[{"issue":"25","key":"2188_CR1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clinical Oncol 26(25):4124\u20134130. doi: 10.1200\/JCO.2008.16.4558","journal-title":"J Clinical Oncol"},{"issue":"14","key":"2188_CR2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329(14):987\u2013994. doi: 10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"issue":"12","key":"2188_CR3","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","volume":"117","author":"DD Weisenburger","year":"2011","unstructured":"Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA, Rudiger T, Pileri S, Nakamura S, Nathwani B, Campo E, Berger F, Coiffier B, Kim WS, Holte H, Federico M, Au WY, Tobinai K, Armitage JO, Vose JM (2011) Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117(12):3402\u20133408. doi: 10.1182\/blood-2010-09-310342","journal-title":"Blood"},{"issue":"7","key":"2188_CR4","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Morabito F, Martelli M, Brusamolino E, Iannitto E, Zaja F, Cortelazzo S, Rigacci L, Devizzi L, Todeschini G, Santini G, Brugiatelli M, Federico M (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103(7):2474\u20132479. doi: 10.1182\/blood-2003-09-3080","journal-title":"Blood"},{"key":"2188_CR5","doi-asserted-by":"crossref","unstructured":"Vose JM (2005) International Peripheral T-Cell Lymphoma (PTCL) clinical and pathologic review project: poor outcome by prognostic indices and lack of efficacy with anthracyclines. Blood 106(811a)","DOI":"10.1182\/blood.V106.11.811.811"},{"issue":"16","key":"2188_CR6","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, Bacci F, Falini B, Motta T, Paulli M, Artusi T, Piccioli M, Zinzani PL, Pileri SA (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24(16):2472\u20132479. doi: 10.1200\/JCO.2005.03.6327","journal-title":"J Clin Oncol"},{"key":"2188_CR7","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, International Agency for Research on Cancer, World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours, 4th edn. International Agency for Research on Cancer, Lyon","edition":"4"},{"issue":"4","key":"2188_CR8","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17(4):1244","journal-title":"J Clin Oncol"},{"issue":"1","key":"2188_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/JCM.10.1.75-79.1979","volume":"10","author":"J Nikoskelainen","year":"1979","unstructured":"Nikoskelainen J, Neel EU, Stevens DA (1979) Epstein-Barr virus-specific serum immunoglobulin A as an acute-phase antibody in infectious mononucleosis. J Clin Microbiol 10(1):75\u201379","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2188_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1651-2227.1998.tb01377.x","volume":"87","author":"M Okano","year":"1998","unstructured":"Okano M (1998) Epstein-Barr virus infection and its role in the expanding spectrum of human diseases. Acta Paediatr 87(1):11\u201318","journal-title":"Acta Paediatr"},{"issue":"3","key":"2188_CR11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/CMR.1.3.300","volume":"1","author":"M Okano","year":"1988","unstructured":"Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT (1988) Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev 1(3):300\u2013312","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"2188_CR12","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s12032-011-0011-0","volume":"29","author":"PP Xu","year":"2012","unstructured":"Xu PP, Wang Y, Shen Y, Wang L, Shen ZX, Zhao WL (2012) Prognostic factors of Chinese patients with T\/NK-cell lymphoma: a single institution study of 170 patients. Med Oncol 29(3):2176\u20132182. doi: 10.1007\/s12032-011-0011-0","journal-title":"Med Oncol"},{"issue":"3","key":"2188_CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1040-8428(02)00117-8","volume":"44","author":"S Imashuku","year":"2002","unstructured":"Imashuku S (2002) Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44(3):259\u2013272","journal-title":"Crit Rev Oncol Hematol"},{"key":"2188_CR14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-6-77","volume":"6","author":"QP Yang","year":"2011","unstructured":"Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY, Bi CF, Zuo Z, Wang XQ, Huang J, Dai L, Liu WP (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6:77. doi: 10.1186\/1746-1596-6-77","journal-title":"Diagn Pathol"},{"issue":"2","key":"2188_CR15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/annonc\/mdi037","volume":"16","author":"WY Au","year":"2005","unstructured":"Au WY, Ma SY, Chim CS, Choy C, Loong F, Lie AK, Lam CC, Leung AY, Tse E, Yau CC, Liang R, Kwong YL (2005) Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years. Ann Oncol 16(2):206\u2013214. doi: 10.1093\/annonc\/mdi037","journal-title":"Ann Oncol"},{"issue":"2","key":"2188_CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00277-008-0544-2","volume":"88","author":"Y Lee","year":"2009","unstructured":"Lee Y, Uhm JE, Lee HY, Park MJ, Kim H, Oh SJ, Jang JH, Kim K, Jung CW, Ahn YC, Park K, Ko YH, Kim WS (2009) Clinical features and prognostic factors of patients with \u201cperipheral T cell lymphoma, unspecified\u201d. Ann Hematol 88(2):111\u2013119. doi: 10.1007\/s00277-008-0544-2","journal-title":"Ann Hematol"},{"issue":"2","key":"2188_CR17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdq359","volume":"22","author":"G Gutierrez-Garcia","year":"2011","unstructured":"Gutierrez-Garcia G, Garcia-Herrera A, Cardesa T, Martinez A, Villamor N, Ghita G, Martinez-Trillos A, Colomo L, Setoain X, Rodriguez S, Gine E, Campo E, Lopez-Guillermo A (2011) Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol 22(2):397\u2013404. doi: 10.1093\/annonc\/mdq359","journal-title":"Ann Oncol"},{"issue":"2","key":"2188_CR18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12185-013-1383-z","volume":"98","author":"Y Torimoto","year":"2013","unstructured":"Torimoto Y, Sato K, Ikuta K, Hayashi T, Hirayama Y, Inamura J, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Mori A, Ota S, Sakai H, Shigematsu A, Shindo M, Shinzaki H, Takahashi F, Takimoto R, Tanaka J, Yamamoto S, Kohgo Y, Fukuhara T (2013) A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group. Int J Hematol 98(2):171\u2013178. doi: 10.1007\/s12185-013-1383-z","journal-title":"Int J Hematol"},{"key":"2188_CR19","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1038\/bcj.2012.23","volume":"2","author":"HN Lin","year":"2012","unstructured":"Lin HN, Liu CY, Pai JT, Chang FP, Yang CF, Yu YB, Hsiao LT, Chiou TJ, Liu JH, Gau JP, Tzeng CH, Chen PM, Hong YC (2012) How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models? Blood Cancer J 2:e93. doi: 10.1038\/bcj.2012.23","journal-title":"Blood Cancer J"},{"issue":"13","key":"2188_CR20","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","volume":"69","author":"I Ray-Coquard","year":"2009","unstructured":"Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I, Guastalla JP, Bachelot T, Perol D, Chabaud S, Hogendoorn PC, Cassier P, Dufresne A, Blay JY (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69(13):5383\u20135391. doi: 10.1158\/0008-5472.CAN-08-3845","journal-title":"Cancer Res"},{"issue":"8","key":"2188_CR21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.23205","volume":"87","author":"Z Mitrovic","year":"2012","unstructured":"Mitrovic Z, Perry AM, Suzumiya J, Armitage JO, Au WY, Coiffier B, Holte H, Jaffe ES, Monserrat E, Rajan SK, Savage KJ, Tobinai K, Vose JM, Weisenburger DD (2012) The prognostic significance of lymphopenia in peripheral T-cell and natural killer\/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project. Am J Hematol 87(8):790\u2013794. doi: 10.1002\/ajh.23205","journal-title":"Am J Hematol"},{"issue":"2","key":"2188_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000227554","volume":"53","author":"S Monfardini","year":"1996","unstructured":"Monfardini S, Sorio R, Cavalli F, Cerny TH, Van Glabbeke M, Kaye S, Smyth JF (1996) Pentostatin (2\u2032-deoxycoformycin, dCF) in patients with low-grade (B-T-cell) and intermediate- and high-grade (T-cell) malignant lymphomas: phase II study of the EORTC Early Clinical Trials Group. Oncology 53(2):163\u2013168","journal-title":"Oncology"},{"issue":"3","key":"2188_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/1055-9965.EPI-06-1056","volume":"16","author":"EA Engels","year":"2007","unstructured":"Engels EA (2007) Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):401\u2013404","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"13","key":"2188_CR24","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","volume":"108","author":"J Dupuis","year":"2006","unstructured":"Dupuis J, Emile JF, Mounier N, Gisselbrecht C, Martin-Garcia N, Petrella T, Bouabdallah R, Berger F, Delmer A, Coiffier B, Reyes F, Gaulard P (2006) Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) study. Blood 108(13):4163\u20134169. doi: 10.1182\/blood-2006-04-017632","journal-title":"Blood"},{"issue":"1","key":"2188_CR25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","volume":"104","author":"WY Au","year":"2004","unstructured":"Au WY, Pang A, Choy C, Chim CS, Kwong YL (2004) Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 104(1):243\u2013249. doi: 10.1182\/blood-2003-12-4197","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2188-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2188-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2188-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T02:38:20Z","timestamp":1598236700000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2188-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2188"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2188-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,6]]}}}